tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders StocksMarket MoversTipRanks 50 IndexAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by UpsideTop ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Research Tools
Trending StocksCompare StocksCompare ETFsTrump Dashboard
New
Daily Feeds
Daily Analyst RatingsDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksFDA CalendarMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Class Actions
Stock ScreenerETF Screener
Popular
Penny Stock ScreenerTechnical Analysis Screener
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Trending News
More News >
Education
Personal FinanceHow To Use TipRanksTipRanks LabsGlossaryFAQs
About Us
About TipRanksContact UsReviewsMobile APP
Working with TipRanks
Enterprise SolutionsAdvertise with UsTop Online BrokersBecome an AffiliateTipRanks News Wire
Follow Us
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders Stocks
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Trump Dashboard
New
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
FDA Calendar
Market Holidays
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Private Companies
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Enterprise Solutions
Plans & Pricing
Education
How To Use TipRanks
TipRanks Labs
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
Advertisement
Advertisement

GB:AGY Stock Latest News

Allergy Therapeutics seals £40m Hayfin facility and simplifies capital structure
Company AnnouncementsAllergy Therapeutics seals £40m Hayfin facility and simplifies capital structure
3h ago
Allergy Therapeutics Bolsters Board and Strategy Team to Drive Global Expansion
PremiumCompany Announcements
Allergy Therapeutics Bolsters Board and Strategy Team to Drive Global Expansion
24d ago
Allergy Therapeutics Wins Strong Shareholder Backing at 2026 AGM
PremiumCompany Announcements
Allergy Therapeutics Wins Strong Shareholder Backing at 2026 AGM
25d ago
Allergy Therapeutics Grants Performance-Linked Share Options to Senior Management
PremiumCompany Announcements
Allergy Therapeutics Grants Performance-Linked Share Options to Senior Management
26d ago
Allergy Therapeutics lifts revenues and launches Grassmuno as German TAV transition accelerates
PremiumCompany Announcements
Allergy Therapeutics lifts revenues and launches Grassmuno as German TAV transition accelerates
1M ago
Allergy Therapeutics Adds Asia-Focused Expertise to Board Ahead of Potential Hong Kong Listing
PremiumCompany AnnouncementsAllergy Therapeutics Adds Asia-Focused Expertise to Board Ahead of Potential Hong Kong Listing
2M ago
Allergy Therapeutics Wins Shareholder Mandate for Potential Equity Raise Ahead of Hong Kong Dual Listing
Premium
Company Announcements
Allergy Therapeutics Wins Shareholder Mandate for Potential Equity Raise Ahead of Hong Kong Dual Listing
2M ago
Allergy Therapeutics Secures German Approval for Grassmuno® Immunotherapy
Premium
Company Announcements
Allergy Therapeutics Secures German Approval for Grassmuno® Immunotherapy
2M ago
Allergy Therapeutics Gains German Approval for Grassmuno Immunotherapy
PremiumCompany Announcements
Allergy Therapeutics Gains German Approval for Grassmuno Immunotherapy
2M ago
Allergy Therapeutics Plans Potential Equity Raise Ahead of Hong Kong Listing
PremiumCompany Announcements
Allergy Therapeutics Plans Potential Equity Raise Ahead of Hong Kong Listing
2M ago
Allergy Therapeutics Reports Stable Financials and Strategic Growth Initiatives
PremiumCompany Announcements
Allergy Therapeutics Reports Stable Financials and Strategic Growth Initiatives
2M ago
Allergy Therapeutics Achieves Key Milestone in Peanut Allergy Treatment Trial
PremiumCompany Announcements
Allergy Therapeutics Achieves Key Milestone in Peanut Allergy Treatment Trial
3M ago
Allergy Therapeutics Considers Dual Listing on HKEX to Expand Asian Market Presence
PremiumCompany AnnouncementsAllergy Therapeutics Considers Dual Listing on HKEX to Expand Asian Market Presence
4M ago
Allergy Therapeutics Advances Phase III Trial for Paediatric Grass Allergy Treatment
Premium
Company Announcements
Allergy Therapeutics Advances Phase III Trial for Paediatric Grass Allergy Treatment
4M ago
Allergy Therapeutics Strengthens Financial Position with New Loan Facility
Premium
Company Announcements
Allergy Therapeutics Strengthens Financial Position with New Loan Facility
4M ago
Allergy Therapeutics Advances Peanut Allergy Vaccine with Positive Trial Results
PremiumCompany Announcements
Allergy Therapeutics Advances Peanut Allergy Vaccine with Positive Trial Results
4M ago
Allergy Therapeutics’ VLP Peanut Trial: A Potential Game-Changer for Peanut Allergy Treatment
PremiumCompany Announcements
Allergy Therapeutics’ VLP Peanut Trial: A Potential Game-Changer for Peanut Allergy Treatment
6M ago
AGY
Allergy Therapeutics Advances VLP Peanut Study: A Potential Breakthrough in Allergy Treatment
PremiumCompany Announcements
Allergy Therapeutics Advances VLP Peanut Study: A Potential Breakthrough in Allergy Treatment
6M ago
Allergy Therapeutics Strengthens Evidence for Grass MATA MPL Immunotherapy
PremiumCompany Announcements
Allergy Therapeutics Strengthens Evidence for Grass MATA MPL Immunotherapy
7M ago
Allergy Therapeutics Maintains Stable Performance Amid Strategic Growth Initiatives
PremiumCompany AnnouncementsAllergy Therapeutics Maintains Stable Performance Amid Strategic Growth Initiatives
7M ago
Allergy Therapeutics Issues Over 250 Million Warrants Amid Financial Strategy
Premium
Company Announcements
Allergy Therapeutics Issues Over 250 Million Warrants Amid Financial Strategy
8M ago
Allergy Therapeutics Unveils Promising Research at EAACI 2025
Premium
Company Announcements
Allergy Therapeutics Unveils Promising Research at EAACI 2025
9M ago

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >